How GLP-1s Slow Gastric Emptying

Two of the most talked-about effects of GLP-1 medications — the lasting fullness people describe and the nausea many experience early on — share much of a single underlying cause. Both trace back to how these drugs change the speed at which your stomach empties. Understanding that one mechanism explains a surprising amount of the lived experience of taking them.

What gastric emptying is

After you eat, your stomach gradually releases its contents into the small intestine. The pace of that release is gastric emptying, and it is tightly regulated by hormonal and neural signals. GLP-1 is one of the body’s natural regulators here. GLP-1 medications amplify that signal, and one consequence is that the stomach empties more slowly than usual.

A 2024 review in The Journal of Clinical Endocrinology & Metabolism describes the specific changes: relaxation of the gastric fundus, increased gastric compliance, inhibited antral contractility, and increased pyloric tone — coordinated effects that slow how fast a meal leaves the stomach.

Slowed gastric emptying is not a side effect bolted onto these drugs. It is part of the same mechanism that produces the fullness people are seeking — though the appetite effect is thought to be primarily centrally mediated, in the brain.

Why this produces fullness — and nausea

When the stomach holds onto food longer, two things tend to follow.

• Prolonged fullness — food lingering keeps stretch receptors signaling that you are satisfied, so you feel full longer and tend to eat less at the next meal.
• Nausea and early satiety — that same delayed emptying can feel like heaviness, queasiness, or getting full unusually fast, especially in the first weeks or after a dose increase.

An important caveat from the evidence: the presence or absence of GI symptoms does not reliably predict whether emptying is actually delayed, and nausea may also be driven by GLP-1 acting directly on nausea centers in the brain. So while gastric emptying and nausea are linked, they are not a simple one-to-one relationship.

Why it often eases over time

For many people, the nausea fades — and there is a mechanistic reason. With long-acting agents like liraglutide and semaglutide, the slowing of gastric emptying attenuates over weeks of continued use (a tachyphylaxis effect), even as appetite and glucose benefits persist. Short-acting agents do not show the same fade. This is part of why these drugs are typically started low and increased gradually. Eating smaller, less greasy meals tends to help, because large or high-fat meals stress an already-slowed stomach. None of this is universal — tolerance varies a great deal.

The takeaway

The fullness that makes GLP-1s effective and the nausea that makes them unpleasant come substantially from the same place: a stomach that empties more slowly. Importantly, the gastric slowing partially wears off over weeks with long-acting drugs, which helps explain why early nausea often improves — and why gradual dose escalation makes sense. Individual tolerance still matters.

Sources

• Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide — JCEM, 2024